WOOF:NGS-VCA Inc.

EQUITY | Health Care Providers | Nasdaq Global Select

Last Closing

USD 92.98

Change

0.00 (0.00)%

Market Cap

USD 5.16B

Volume

0.02M

Analyst Target

USD 87.33
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

VCA Inc provides veterinary services and diagnostic testing to support veterinary care and sells diagnostic imaging equipment and other medical technology products and related services to the veterinary market.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2019-07-15 )

Largest Industry Peers for Health Care Providers

ETFs Containing WOOF

KATZ:XETRA 0.00 % 0.00 %

N/A

N/A
PETZ:LSE 0.00 % 0.00 %

N/A

N/A
PETZ:SW 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health Care Providers) Market Performance vs. Exchange (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain 160.08% N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 160.08% N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 21.08% N/A N/A N/A N/A
Dividend Return 21.08% N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 22.70% N/A N/A N/A N/A
Risk Adjusted Return 92.83% N/A N/A N/A N/A
Market Capitalization 5.16B N/A N/A N/A N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Health Care Providers) Ratio vs. Market (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 22.80 N/A N/A
Price/Book Ratio 19.78 N/A N/A
Price / Cash Flow Ratio 18.40 N/A N/A
Price/Free Cash Flow Ratio 504.30 N/A N/A
Management Effectiveness  
Return on Equity N/A N/A N/A
Return on Invested Capital N/A N/A N/A
Return on Assets N/A N/A N/A
Debt to Equity Ratio N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:

There is nothing we particularly dislike